click below
click below
Normal Size Small Size show me how
toxicology ch 5
| Question | Answer |
|---|---|
| Disposition of xenobiotics | composite of absorption, distribution, biotransformation, & elimination |
| Primary barriers | .Skin 2.Lungs 3.Alimentary canal |
| To become toxic, must cross biological membranes | .Passive transport 2.Specialized transport |
| Fick’s law | passive movement from high to low concentration 1.Paracellular diffusion 2.Transcellular diffusion 3.Filtration |
| Transport rate depends on | partition coefficient, P - determined by [X] in octanol/ [X] in water (describes degree of lipid solubility) water = 1 solvent, 1-octanol = 2nd solvent |
| Arrhenius’ theory | many weak organic acids or bases ionize in solution •pH at which acid or base is 50% ionized = its pKa or pKb |
| Brönsted-Lowry acid-base theory | acid = proton (H+) donor, base = proton acceptor •Ionized & nonionized forms of an organic acid represent acid-base pair |
| CELL MEMBRANES: SPECIAL TRANSPORT | Large or lipid-insoluble compounds, including xenobiotics, require special transporters |
| Xenobiotics transporter classes 1.ATP-binding cassette | (ABC) transporters •Active transport •7 subfamilies (A - G) •MDR1 (B subfamily), C subfamily |
| .Solute carriers | •Facilitated diffusion •43 families •Organic-anion transporting peptides (OATPs), Peptide transporters (PEPTs), Multidrug and toxin extrusion (MATE) transporters |
| ABSORPTION | Process by which toxicants/xenobiotics cross body membranes to enter bloodstream is same as other substances |
| ABSORPTION Primary sites | .Gastrointestinal tract 2.Lungs 3.Skin |
| Administration routes | 1.Enteral (sublingual, oral, & rectal) 2.Parenteral (intravenous, intraperitoneal, intramuscular, subcutaneous |
| Oral ingestion | most common route of unintentional toxicant exposure (especially children) & intentional overdoses |
| Organic acids & bases | tend to be absorbed by simple diffusion |
| Amount of chemical entering systemic circulation depends on | 1.Amount absorbed into GI cells 2.Biotransformation by GI cells 3.Extraction by liver into bile (w/ or w/o biotransformation) |
| Presystemic elimination (first-pass effect) | 4.Chelation alters lipid solubility, thus absorption 5.Inhibition of transporters |
| Gases & Vapors | Nose acts as “scrubber” Mucosa covered by film of fluid; hydrophilic gas molecules may dissolve in fluid & be retained in the nose = ¯ systemic exposure, risk to nasal tissues |